Showing 41 - 60 results of 56,394 for search '(( a non decrease ) OR ( 5 ((((fold decrease) OR (point decrease))) OR (mean decrease)) ))', query time: 1.18s Refine Results
  1. 41
  2. 42
  3. 43
  4. 44

    Time course of best-corrected visual acuity (BCVA) in recurrence and non-recurrence groups. by Yasuyuki Sotani (20114144)

    Published 2025
    “…In the non-recurrence group, CRT improved from 482.5 ± 112.8 to 294.7 ± 65.3, 302.0 ± 68.0, 284.7 ± 55.4, 285.3 ± 70.2, 265.2 ± 65.0, and 266.1 ± 78.2 μm at 1, 3, 6, 12, 24, and 36 months, respectively (Kruskal-Wallis test, p < 0.001; <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0332941#pone.0332941.g006" target="_blank">Fig 6</a>).…”
  5. 45
  6. 46
  7. 47
  8. 48
  9. 49
  10. 50
  11. 51
  12. 52

    The <i>P[syt<sup>P-L</sup>]</i> mutation decreases the Ca<sup>2+</sup> affinity of release and vesicular release probability, but the readily releasable pool is unchanged. by Mallory C. Shields (4474210)

    Published 2017
    “…<p>(A) Mean EJP amplitudes from <i>+/-;P[syt<sup>WT</sup>]/+</i> (filled black circles) and <i>+/-;P[syt<sup>P-L</sup>]/+</i> (filled red circles) larvae at Ca<sup>2+</sup> levels ranging from 0.05 mM—5.0 mM. …”
  13. 53
  14. 54
  15. 55
  16. 56
  17. 57
  18. 58
  19. 59

    Treatment with anti-JAM-C antibody decreases the severity of antigen-induced arthritis by Gaby Palmer (636)

    Published 2011
    “…Results shown represent the mean ± SEM for anti-JAM-C antibody-treated (= 5 on day 4, = 6 on day 8, black columns) and isotype-matched control antibody-treated (= 5 at both time points, open columns) mice. …”
  20. 60